PEAK6
CYTK icon

PEAK6’s Cytokinetics CYTK Stock Holding History

PEAK6’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,800
Closed -$2.08M – 2828
2025
Q4 		$2.08M Hold
32,800
– – ﹤0.01% 1411
2025
Q3 		$1.8M Hold
32,800
– – ﹤0.01% 1553
2025
Q2 		$1.08M Hold
32,800
– – ﹤0.01% 1761
2025
Q1 		$1.32M Sell
32,800
-2,500
-7% -$115K ﹤0.01% 1609
2024
Q4 		$1.66M Buy
+35,300
New +$1.83M ﹤0.01% 1525

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PEAK6's CYTK Position: Q2 2025 in Review

PEAK6 sold out of Cytokinetics (CYTK) in Q2 2025, closing a stake of 1,600 shares — an estimated $55.7K sold.

PEAK6 first reported a position in CYTK in Q4 2024 and held it in 2 quarters. The position peaked at $175K in Q4 2024. 311 funds tracked by Wall St. Rank hold CYTK as of Q2 2025.

  • PEAK6 reported no remaining Cytokinetics position as of Q2 2025 after selling out during the quarter.
  • PEAK6 sold 1,600 Cytokinetics shares in Q2 2025, an estimated $55.7K.
  • PEAK6 first reported a position in Cytokinetics in Q4 2024 and held it in 2 quarters.
  • PEAK6's Cytokinetics position peaked at $175K in Q4 2024.
  • 311 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2025.

Based on PEAK6's 13F filing for Q2 2025, filed 14 Aug 2025.